← All trials
NCT02282670
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Nov 1, 2014
- Completion date
- Nov 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 434
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Dong-A PharmaceuticalLead sponsor
- Inje UniversityOverall official - principal investigator
- Seoul National UniversityOverall official - principal investigator
- Catholic University of KoreaOverall official - principal investigator
- Yonsei UniversityOverall official - principal investigator
- Presbyterian medical center, Jeonju, KoreaOverall official - principal investigator
- Sungkyunkwan UniversityOverall official - principal investigator
- Chonnam National UniversityOverall official - principal investigator
- Dong-A UniversityOverall official - principal investigator
- Hanyang UniversityOverall official - principal investigator
- Inha UniversityOverall official - principal investigator
- Jeju National UniversityOverall official - principal investigator
- Wonkwang UniversityOverall official - principal investigator
- Yeungnam UniversityOverall official - principal investigator
- Chungbuk National UniversityOverall official - principal investigator
- Kyungpook UniversityOverall official - principal investigator
- University of UlsanOverall official - principal investigator
- Chonbuk National UniversityOverall official - principal investigator
- KangWon National UniversityOverall official - principal investigator
- Ewha Womans UniversityOverall official - principal investigator
- Pusan National UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.